A Comprehensive Evaluation of the Disease-Modifying Effects of Tafamidis in Patients with Transthyretin Type Familial Amyloid Polyneuropathy

被引：0
|
作者：
Coelho, Teresa
Maia, Luis
da Silva, Ana Martins
Cruz, Marcia Waddington
Plante-Bordeneuve, Violaine
Lozeron, Pierre
Suhr, Ole B.
Campistol, Josep
Conceicao, Isabel
Schmidt, Hartmut
Trigo, Pedro
Packman, Jeff
Grogan, Donna R.
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [21] AN OBSERVATIONAL STUDY ON TAFAMIDIS FOR TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY IN ITALY
    Cortese, A.
    Russo, M.
    Obici, L.
    Cavallaro, T.
    Fabrizi, G. M.
    Manganelli, F.
    Santoro, L.
    Luigetti, M.
    Sabatelli, M.
    Schenone, A.
    Grandis, M.
    Mauro, A.
    Pradotto, L. G.
    Mazzeo, A.
    Gentile, L.
    Piscosquito, G.
    Calabrese, D.
    Vita, G.
    Merlini, G.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S8 - S9
  • [22] Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
    Michelle Stewart
    Denis Keohane
    Sarah Short
    Jose Alvir
    Moh-Lim Ong
    Rajiv Mundayat
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [23] REHABILITATION OF PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Theaudin, M.
    Adams, D.
    De Sousa, A.
    Lemoine, C.
    Morier, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 305 - 305
  • [24] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 315 - 316
  • [25] Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
    Keohane, D.
    Schwartz, J.
    Gundapaneni, B.
    Stewart, M.
    Amass, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 413 - 413
  • [26] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Duca, F.
    Binder, C.
    Capelle, C.
    Aschauer, S.
    Eslam, R. Badr
    Mascherbauer, J.
    Hengstenberg, C.
    Bonderman, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
  • [27] Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
    Denis Keohane
    Jeffrey Schwartz
    Balarama Gundapaneni
    Michelle Stewart
    Leslie Amass
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [28] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Eslam, Roza Badr
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S452 - S452
  • [29] Outcome Measures for Transthyretin Type Familial Amyloid Polyneuropathy
    Coehlo, Teresa
    Merkies, Ingemar
    Vinik, Aaron
    Vinik, Etta J.
    Chan, Jason
    Packman, Jeff
    Grogan, Donna R.
    NEUROLOGY, 2010, 74 (09) : A336 - A336
  • [30] LONG-TERM EFFECTS OF TAFAMIDIS - A NEW THERAPEUTIC OPTION FOR PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP)
    Coelho, T.
    Maia, L.
    Martins da Silva, A.
    Waddington Cruz, M.
    Plante-Bordeneuve, V.
    Suhr, O. B.
    Conceicao, I.
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Harnett, M.
    Grogan, D. R.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S543 - S543
12345